XML 24 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Revenue    
Total revenue $ 1,098,280 $ 962,032
Costs and expenses    
Costs of revenue 262,888 284,892
Sales and marketing expense 61,706 91,939
Product development expense 215,538 210,232
General and administrative expense 5,679,697 4,072,580
Total costs and expenses 6,219,829 4,659,643
Loss from continuing operations (5,121,549) (3,697,611)
Interest income, net 569,016 639,611
Other income, net 146,269 343,045
Loss from continuing operations before income tax benefit (4,406,264) (2,714,955)
Income tax benefit 137,589 27,947
Net loss from continuing operations (4,268,675) (2,687,008)
(Loss) income from discontinued operations, net of income tax expense of $24,357 and $7,695, respectively (4,157,534) 1,619,673
Net loss $ (8,426,209) $ (1,067,335)
Net loss per share of common stock:    
Basic – continuing operations (in Dollars per share) $ (0.48) $ (0.29)
Diluted – continuing operations (in Dollars per share) (0.48) (0.29)
Basic – discontinued operations (in Dollars per share) (0.43) 0.17
Diluted – discontinued operations (in Dollars per share) (0.43) 0.17
Basic (in Dollars per share) (0.91) (0.12)
Diluted (in Dollars per share) $ (0.91) $ (0.12)
Weighted average number of shares of common stock used in calculating net loss per share of common stock:    
Basic (in Shares) 9,227,197 9,222,206
Diluted (in Shares) 9,227,197 9,222,206